Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 24 December 2025

BitMine Immersion Technologies (BMNR) Stock: Latest News, Analyst Forecasts, and What to Watch on Dec. 24, 2025

BitMine Immersion Technologies (BMNR) Stock: Latest News, Analyst Forecasts, and What to Watch on Dec. 24, 2025

December 24, 2025 — BitMine Immersion Technologies, Inc. (NYSE American: BMNR) is ending 2025 as one of the market’s most unusual—and closely watched—crypto-linked equities: a public company that has shifted from mining into what it calls an Ethereum- and Bitcoin-treasury strategy, with disclosures showing it now holds more than 4 million ETH alongside cash and a smaller BTC position. Reuters+2SEC+2 BMNR shares traded around the $29 level in the Christmas Eve session, with the stock’s 52-week range spanning roughly $3.20 to $161.00, underscoring how sharply sentiment has swung as investors debate whether BMNR is a “liquid ETH proxy” or a
24 December 2025
··
Bank of America Stock (BAC) Today: Christmas Eve Trading, Fresh News, Analyst Forecasts and the 2026 Outlook (Dec. 24, 2025)

Bank of America Stock (BAC) Today: Christmas Eve Trading, Fresh News, Analyst Forecasts and the 2026 Outlook (Dec. 24, 2025)

NEW YORK — December 24, 2025 — Bank of America Corporation (NYSE: BAC) is heading into the year-end holiday stretch with its shares hovering near 2025 highs, as investors balance a “Santa rally” tone on Wall Street against questions that matter most for big banks in 2026: the pace of Federal Reserve rate cuts, the shape of the yield curve, credit quality, and how much capital can be returned to shareholders. With U.S. markets operating on a shortened Christmas Eve session and liquidity typically thinner than normal, price action in BAC can look deceptively calm (or suddenly jumpy). The bigger
24 December 2025
·
Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecasts, and Analyst Outlook on Dec. 24, 2025

Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecasts, and Analyst Outlook on Dec. 24, 2025

December 24, 2025 — Zai Lab Limited (NASDAQ: ZLAB, HKEX: 9688) is back in the spotlight after a major regulatory catalyst in China helped lift sentiment around the biopharma name. The company announced that China’s National Medical Products Administration (NMPA) approved COBENFY (xanomeline and trospium chloride) for schizophrenia in adults—a decision that quickly rippled into trading on both its U.S. ADR and Hong Kong listings. Business Wire+1 As of Dec. 24, 2025, Zai Lab’s U.S.-listed ADR was trading around $18.54 intraday (open $18.39, high $19.01), as risk-on buyers reacted to the approval headline and the company’s broader “pipeline-to-commercial” story. MarketBeat
24 December 2025
···
Salesforce (CRM) Stock News Today: Agentforce Momentum, AI Reliability Questions, and Updated Wall Street Forecasts (Dec. 24, 2025)

Salesforce (CRM) Stock News Today: Agentforce Momentum, AI Reliability Questions, and Updated Wall Street Forecasts (Dec. 24, 2025)

Salesforce, Inc. (NYSE: CRM) stock is closing out 2025 with two narratives battling for investor attention: accelerating traction in its Agentforce and Data 360 products, and a growing industry debate about how reliably large language models (LLMs) can “run the business” without guardrails. On December 24, 2025, Salesforce shares traded around $266 and were modestly higher on the day, but the stock remains down roughly ~21% year-to-date after a volatile year that saw the shares swing from a 52-week high of $367.09 (Jan. 28, 2025) to a 52-week low of $221.96 (Nov. 21, 2025). FinanceCharts+1 Below is what’s driving the
24 December 2025
··
Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next

Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next

Wave Life Sciences Ltd. (NASDAQ: WVE) is ending 2025 as one of biotech’s most watched “story stocks”—the kind that can go from sleepy to screaming in a single premarket headline, then spend weeks digesting what just happened. On December 24, 2025, Wave shares traded in the high teens (around ~$18), still hovering near the re-rated levels that followed its early obesity readout and a sizable capital raise earlier this month. Multiple market data sources showed WVE around $18.1–$18.5 intraday, with the day’s range roughly $17.49 to ~$18.5. StockAnalysis+2Investing.com Australia+2 Below is a consolidated, publication-ready look at the most relevant WVE
24 December 2025
·
Intel Stock INTC Slips as Nvidia Pauses 18A Test: Latest News, Forecasts, and What Matters Next

Intel Stock INTC Slips as Nvidia Pauses 18A Test: Latest News, Forecasts, and What Matters Next

Intel Corporation stock (NASDAQ: INTC) traded lower on Wednesday, December 24, 2025, as investors digested a fresh headline that strikes at the heart of Intel’s turnaround narrative: whether its next-generation manufacturing technology is ready to win — and keep — the world’s biggest chip designers. INTC was last around $35.97, down about 1% on the day, after swinging between $34.48 and $36.49 in a holiday-thinned session. The timing matters. Christmas Eve trading in the U.S. was shortened, volumes were lighter than usual, and the broader market tone was relatively calm — even upbeat — with the S&P 500 touching an
24 December 2025
·
Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics, Inc. (NASDAQ: TVTX) is ending 2025 with a bang. In the holiday-shortened U.S. trading session on Wednesday, December 24, 2025, TVTX surged sharply—pushing to fresh highs as investors recalibrated around two big themes: accelerating commercial execution for FILSPARI (sparsentan) and a looming FDA decision that could expand the drug into a second major kidney disease indication. StockAnalysis+2New York Stock Exchange+2 TVTX stock action on Dec. 24, 2025: a thin-session breakout with big numbers In early trading on Dec. 24, TVTX was up roughly 15% and changing hands around the low $40 range—an outsized move for a single session,
24 December 2025
·
UiPath (PATH) Stock Jumps on S&P MidCap 400 Addition: Price Move, Analyst Targets, and What to Watch Next

UiPath (PATH) Stock Jumps on S&P MidCap 400 Addition: Price Move, Analyst Targets, and What to Watch Next

NEW YORK — December 24, 2025 — UiPath Inc. (NYSE: PATH) is having a headline-grabbing Christmas Eve session, with shares climbing sharply after S&P Dow Jones Indices selected UiPath for inclusion in the S&P MidCap 400. In late-morning U.S. trading, PATH hovered around $17.25, up roughly 8% on the day, after opening higher and trading between roughly $16.70 and $17.36. StockAnalysis The move is landing during a holiday-shortened session (U.S. equities close early on Christmas Eve), which can magnify price swings as liquidity thins out. Investopedia UiPath stock price today: what the market is reacting to The catalyst isn’t a
24 December 2025
·
Nike Stock (NKE) Jumps on Tim Cook’s $3M Share Buy as Turnaround Pressures Mount: News, Forecasts and Analysis for Dec. 24, 2025

Nike Stock (NKE) Jumps on Tim Cook’s $3M Share Buy as Turnaround Pressures Mount: News, Forecasts and Analysis for Dec. 24, 2025

Nike, Inc. (NYSE: NKE) stock is getting a rare kind of holiday-season lift: a high-profile insider purchase. In the holiday-shortened U.S. trading session on Wednesday, December 24, 2025, shares climbed roughly 4%–5% after filings showed Apple CEO Tim Cook—also Nike’s long-time board member and lead independent director—bought about $3 million worth of Nike shares on the open market. Reuters+1 The move arrives at a sensitive moment for investors. Nike shares had fallen sharply after the company’s latest quarterly results and guidance, as management works through a wide-ranging reset under CEO Elliott Hill. Cook’s purchase doesn’t erase the fundamentals overnight—but it
24 December 2025
··
Home Depot Stock (HD) News Today, Dec. 24, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Home Depot Stock (HD) News Today, Dec. 24, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Home Depot, Inc. (NYSE: HD) is trading through a shortened Christmas Eve session with investors juggling mixed signals: upbeat Wall Street ratings, cautious earnings-revision trends, and a steady drumbeat of institutional-position headlines. Meanwhile, the broader market’s “Santa rally” narrative is picking up steam as the S&P 500 notched a fresh record intraday high on Wednesday. Reuters+1 As of the latest available trade on December 24, 2025, HD shares were around $347.51, up roughly 0.7% on the day, after opening near $344 and trading in the mid-$340s range. MarketWatch Below is a complete roundup of the key HD stock news, forecasts,
24 December 2025
·
Procter & Gamble (PG) Stock Today: Analyst Upgrades, Tariff Pressures, and a CEO Change Set the Tone for 2026

Procter & Gamble (PG) Stock Today: Analyst Upgrades, Tariff Pressures, and a CEO Change Set the Tone for 2026

December 24, 2025 — Procter & Gamble (NYSE: PG) is ending 2025 in a familiar role for markets: a defensive bellwether that investors watch closely for clues about consumer demand, pricing power, and how quickly households are trading down—or trading up—when the economy gets choppy. On December 24, 2025, with U.S. markets operating in a holiday-shortened session and broad indexes still hovering near record territory, P&G stock is trying to stabilize after a rough stretch that pushed shares toward early-December lows. Investopedia+1 Below is what’s moving Procter & Gamble stock right now, what Wall Street is forecasting, and the specific
24 December 2025
·
Polestar Stock (PSNY) Surges on Fresh Funding: Latest News, Analyst Forecasts, and What Investors Are Watching (Dec. 24, 2025)

Polestar Stock (PSNY) Surges on Fresh Funding: Latest News, Analyst Forecasts, and What Investors Are Watching (Dec. 24, 2025)

Polestar Automotive Holding UK PLC (Nasdaq: PSNY) is back in the market spotlight on December 24, 2025, with the stock rallying sharply as investors digest a string of balance-sheet moves designed to extend liquidity, reduce leverage, and keep the company’s Nasdaq listing in good standing. Business Wire+2Reuters+2 The quick version: PSNY traded around $17.09, up roughly 13% on the day, after Polestar announced $300 million in new equity, a plan for ~$300 million of debt to convert into equity, and a Geely-backed term loan facility of up to $600 million. Those are big numbers for a company that has been
24 December 2025
··
Merck Stock Forecast and News Roundup for December 24, 2025: MRK Hits a New 52-Week High as Wall Street Reprices 2026 Catalysts

Merck Stock Forecast and News Roundup for December 24, 2025: MRK Hits a New 52-Week High as Wall Street Reprices 2026 Catalysts

Merck & Company, Inc. stock is ending 2025 on a strong note. On December 24, 2025, shares of Merck (MRK) pushed to a fresh 12‑month high around the $106 level, extending a powerful late‑year rally that has put the pharma bellwether back in the spotlight. MarketBeat+2Investing.com+2 This move isn’t happening in a vacuum. Today’s MRK price action sits at the intersection of three market themes that have dominated Merck headlines into Christmas Eve: Below is a comprehensive, publication-ready roundup of the current news, forecasts, and analysis investors are reading as of December 24, 2025, and what it could mean for
24 December 2025
··
Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) stock surged in intraday trading on Wednesday, December 24, 2025, after the company released a fresh update on EDG-7500, its investigational therapy for hypertrophic cardiomyopathy (HCM). By late morning, shares were trading around $26.37—up roughly 21% versus the prior close—after swinging between about $21.30 and $27.05 on the day, with volume above 2.2 million shares. The move follows a company announcement that it has completed Parts B and C of its Phase 2 CIRRUS-HCM trial and reported favorable interim safety observations from Part D—an update that several market outlets characterized as a meaningful de-risking moment
24 December 2025
·
Johnson & Johnson Stock Today: JNJ Holds Near $207 on Dec. 24, 2025 as Talc Verdict, Drug-Price Pressure and Q4 Earnings Take Center Stage

Johnson & Johnson Stock Today: JNJ Holds Near $207 on Dec. 24, 2025 as Talc Verdict, Drug-Price Pressure and Q4 Earnings Take Center Stage

Johnson & Johnson (NYSE: JNJ) is trading through a holiday-shortened Christmas Eve session with investors balancing a familiar mix of defensive appeal and headline risk. On Wednesday, December 24, 2025, J&J shares hovered around $207 in late-morning trade, keeping the healthcare bellwether close to its recent highs even as the company faces fresh legal scrutiny and renewed policy pressure on U.S. drug pricing. StockAnalysis The immediate backdrop matters: U.S. markets are closing early at 1 p.m. ET for Christmas Eve, a schedule that can amplify moves and distort volume signals—especially for mega-caps like J&J that often act as “parking spots”
24 December 2025
···
Citigroup Stock News (NYSE: C) on Dec. 24, 2025: Regulatory Relief, Banamex Progress, and Wall Street Forecasts for 2026

Citigroup Stock News (NYSE: C) on Dec. 24, 2025: Regulatory Relief, Banamex Progress, and Wall Street Forecasts for 2026

NEW YORK — Citigroup, Inc. (NYSE: C) is closing out 2025 with a resurgence that has put C stock back on many investors’ watchlists. In the holiday-shortened session on Wednesday, Dec. 24, 2025, Wall Street traded close to record territory amid thin volumes, while bank shares remained in focus after a string of December headlines around regulatory progress, strategic streamlining, and improving profitability expectations. Reuters For Citigroup specifically, the story going into year-end is less about a single “Christmas Eve catalyst” and more about a stack of developments in the past two weeks that has helped reframe the Citi turnaround
24 December 2025
·
ServiceNow Stock (NYSE: NOW) News Today: $7.75B Armis Deal, CEO Contract Extension, and 2026 Analyst Forecasts (Dec. 24, 2025)

ServiceNow Stock (NYSE: NOW) News Today: $7.75B Armis Deal, CEO Contract Extension, and 2026 Analyst Forecasts (Dec. 24, 2025)

ServiceNow, Inc. (NYSE: NOW) is back in the spotlight on December 24, 2025, as investors weigh two major developments: the company’s $7.75 billion all-cash agreement to acquire cybersecurity firm Armis and a new CEO contract extension for Bill McDermott through 2030. Add in the recent 5‑for‑1 stock split that reset the share price and made older price targets harder to compare, and you have a stock that’s suddenly a daily headline again. Below is a detailed, publication-ready breakdown of today’s ServiceNow stock news, what analysts are forecasting, and the key bull/bear arguments shaping NOW’s outlook into 2026. ServiceNow stock price
24 December 2025
··
Warner Bros. Discovery (WBD) Series A Stock: Latest News, Deal Battle Updates, and Wall Street Forecasts on Dec. 24, 2025

Warner Bros. Discovery (WBD) Series A Stock: Latest News, Deal Battle Updates, and Wall Street Forecasts on Dec. 24, 2025

Warner Bros. Discovery, Inc. Series A Common Stock (NASDAQ: WBD) is ending 2025 as one of the most deal-driven names in U.S. media—caught between a signed Netflix agreement and an aggressive, sweetened hostile bid from Paramount Skydance. On December 24, 2025, WBD shares traded around $29.18, positioning the stock neatly between Netflix’s $27.75 per share cash-and-stock structure (plus a planned networks spin-off) and Paramount Skydance’s $30.00 per share all-cash tender offer for the entire company. Reuters+1 That “in-the-middle” price is the market’s way of saying: this is no longer just a fundamentals story. It’s a high-stakes, multi-path outcome story—one where
24 December 2025
·
Exxon Mobil Stock (XOM) News and Forecast for Dec. 24, 2025: Sakhalin-1 Deadline Extended, Oil Prices Rebound, and Analysts See More Upside

Exxon Mobil Stock (XOM) News and Forecast for Dec. 24, 2025: Sakhalin-1 Deadline Extended, Oil Prices Rebound, and Analysts See More Upside

Exxon Mobil Corporation stock (NYSE: XOM) traded around $119.62 in holiday-thinned action on Wednesday, Dec. 24, 2025, as investors balanced a fresh geopolitical headline tied directly to Exxon’s long-running Russia exit, a late-December rebound in crude prices, and a steady drumbeat of analyst targets clustering in the low $130s. With U.S. markets operating on a shortened Christmas Eve session (stocks closing early), price moves across energy names are being amplified by lighter volumes—often making “headline sensitivity” more pronounced than on a normal trading day. Investopedia Below is what matters most for Exxon Mobil stock today: the Russia/Sakhalin-1 update, the crude-oil
24 December 2025
···
Robinhood Stock (NASDAQ: HOOD) News Today: Holiday Trading, Prediction-Markets Push, and Wall Street Price Targets on Dec. 24, 2025

Robinhood Stock (NASDAQ: HOOD) News Today: Holiday Trading, Prediction-Markets Push, and Wall Street Price Targets on Dec. 24, 2025

December 24, 2025 Robinhood Markets, Inc. stock (NASDAQ: HOOD) is trading in a holiday-shortened Christmas Eve session, with markets set to close early and volumes expected to stay thin. In that kind of tape, even modest moves in crypto prices and risk appetite can show up quickly across retail-brokerage and crypto-exposed names—especially a stock like Robinhood, which has become one of 2025’s standout momentum stories. Below is what investors are tracking as of Dec. 24, 2025, across the major news wires and widely-circulated research/market notes: recent catalysts, today’s trading context, and the latest analyst targets and valuation debates shaping the
24 December 2025
·
1 … 639 640 641 642 643 … 1,171

Stock Market Today

Oil stocks jump on Iran risk lift for crude — what to watch before Monday

Oil stocks jump on Iran risk lift for crude — what to watch before Monday

7 February 2026
U.S. oil stocks surged Friday as crude prices rose on renewed Middle East tensions. Exxon Mobil gained 2.0%, ConocoPhillips 2.5%, and Occidental Petroleum 2.7%. Refiners rallied after a national union deal eased strike risk, though BP’s Whiting plant faces a local dispute. Brent settled at $68.05 a barrel, up 0.74%.
Silver price rebound masks fresh stress after CME lifts margins again

Silver price rebound masks fresh stress after CME lifts margins again

7 February 2026
Spot silver surged 8.6% to $77.33 an ounce Friday after dropping below $65, but still lost over 8.7% for the week. CME Group raised margin requirements for COMEX silver futures to 18% from 15%, effective after Feb. 6. China’s UBS SDIC Silver Futures Fund hit its 10% down limit for a fifth session. Traders await key U.S. jobs and inflation data next week.
Gold price near $5,000: China keeps buying as CME margin hikes raise the stakes

Gold price near $5,000: China keeps buying as CME margin hikes raise the stakes

7 February 2026
China’s central bank raised gold reserves for a 15th month in January, reaching 74.19 million ounces worth $369.58 billion. Gold prices swung sharply, hitting a record near $5,600 before dropping to $4,403.24. CME Group hiked COMEX gold futures margins to 9% after recent volatility. U.S. jobs and inflation data are due next week after a delay.
Go toTop